GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jingxin Pharmaceutical Co Ltd (SZSE:002020) » Definitions » Other Operating Expense

Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) Other Operating Expense : ¥210 Mil (TTM As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Jingxin Pharmaceutical Co Other Operating Expense?

Zhejiang Jingxin Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2025 was ¥-5 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥210 Mil.

Zhejiang Jingxin Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2024 (¥-162 Mil) to Dec. 2024 (¥257 Mil) but then declined from Dec. 2024 (¥257 Mil) to Mar. 2025 (¥-5 Mil).

Zhejiang Jingxin Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2022 (¥310 Mil) to Dec. 2023 (¥298 Mil) and declined from Dec. 2023 (¥298 Mil) to Dec. 2024 (¥210 Mil).


Zhejiang Jingxin Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Zhejiang Jingxin Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Jingxin Pharmaceutical Co Other Operating Expense Chart

Zhejiang Jingxin Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 210.48 273.68 310.31 297.92 210.30

Zhejiang Jingxin Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.04 119.98 -162.12 257.49 -5.32

Zhejiang Jingxin Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥210 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Jingxin Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Zhejiang Jingxin Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jingxin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.800 Xinchang East Road, Yulin subdistrict, Zhejiang Province, Xinchang, CHN, 312500
Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.
Executives
Wang Neng Neng Director
Chen Shao Bi Executives
Wang Guang Qiang Supervisors
Lv Gang Director
Zhou Lin Executives
Yu Yi Ping Supervisors
Chen Mei Li Directors, executives
Zhang Li Wa Directors, executives
Wu Zheng Jie Director

Zhejiang Jingxin Pharmaceutical Co Headlines

No Headlines